CRF1 antagonist: Phase II started

By WIR Staff | Jan 1, 2007 | 8:00 AM GMT

GSK began a double-blind, placebo-controlled Phase II trial

Read the full 85 word article

How to gain access

Continue reading with a
two-week free trial.